Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study

被引:225
作者
Battaglia, J [1 ]
Moss, S [1 ]
Rush, J [1 ]
Kang, J [1 ]
Mendoza, R [1 ]
Leedom, L [1 ]
Dubin, W [1 ]
McGlynn, C [1 ]
Goodman, L [1 ]
机构
[1] ALASKA PSYCHIAT INST,ANCHORAGE,AK
关键词
haloperidol; lorazepam; psychotic agitation; rapid tranquilization;
D O I
10.1016/S0735-6757(97)90119-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rapid tranquilization is a routinely practiced method of calming agitated psychotic patients by use of neuroleptics, benzodiazepines, or both in combination, Although several studies have examined the efficacy of the three approaches, none have compared these treatments in a prospective, randomized, double-blind, multicenter trial. Ninety eight psychotic, agitated, and aggressive patients (73 men and 25 women) were prospectively enrolled during an 18-month period in emergency departments in five university or general hospitals. Patients were randomly assigned to receive intramuscular injections of lorazepam (2 mg), haloperidol (5 mg), or both in combination, Patients in each treatment group received 1 to 6 injections of the same study drug within 12 hours, based on clinical need, They were evaluated hourly after the first injection until at least 12 hours after the last. Efficacy was assessed on the Agitated Behavior Scale (ABS), a modified Brief Psychiatric Rating Scale (MBPRS), Clinical Global Impressions (CGI) scale, and an Alertness Scale. Effective symptom reduction was achieved in each treatment group with significant (P < .01) mean decreases from baseline at every hourly ABS evaluation. Significant (P < .05) mean differences on the ABS (hour 1) and MBPRS (hours 2 and 3) suggest that tranquilization was most rapid in patients receiving the combination treatment, Study event incidence (side effects) did not differ significantly between treatment groups, although patients receiving haloperidol alone tended to have more extrapyramidal system symptoms, The superior results produced by the combination treatment support the use of lorazepam plus haloperidol as the treatment of choice for acute psychotic agitation. (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:335 / 340
页数:6
相关论文
共 50 条
  • [31] Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial
    Edmée JM Schrijver
    Oscar J de Vries
    Astrid Verburg
    Karola de Graaf
    Pierre M Bet
    Peter M van de Ven
    Ad M Kamper
    Sabine HA Diepeveen
    Sander Anten
    Andrea Siegel
    Esther Kuipéri
    Anne M Lagaay
    Rob J van Marum
    Astrid M van Strien
    Leo Boelaarts
    Douwe Pons
    Mark HH Kramer
    Prabath WB Nanayakkara
    BMC Geriatrics, 14
  • [32] Intravenous promethazine versus lorazepam for the treatment of peripheral vertigo in the emergency department: A double blind, randomized clinical trial of efficacy and safety
    Amini, Afshin
    Heidari, Kamran
    Asadollahi, Shadi
    Habibi, Tahereh
    Shahrami, Ali
    Mansouri, Behnam
    Kariman, Hamidreza
    JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION, 2014, 24 (01): : 39 - 47
  • [33] Amitriptyline vs. lorazepam in the treatment of opiate-withdrawal insomnia: a randomized double-blind study
    Srisurapanont, M
    Jarusuraisin, N
    ACTA PSYCHIATRICA SCANDINAVICA, 1998, 97 (03) : 233 - 235
  • [34] Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study
    Xiang Yang Zhang
    Dong Feng Zhou
    Lian Yuan Cao
    Pei Yan Zhang
    Gui Ying Wu
    Yu Cun Shen
    Psychopharmacology, 2005, 178 : 35 - 40
  • [35] Efficacy of haloperidol vs levosulpiride injection in patients with acute psychosis: a randomized double-blind study
    Lavania, Sagar
    Praharaj, Samir Kumar
    INDIAN JOURNAL OF PSYCHIATRY, 2015, 57 (05) : S147 - S148
  • [36] Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study
    Zhang, XY
    Zhou, DF
    Cao, LY
    Zhang, PY
    Wu, GY
    Shen, YC
    PSYCHOPHARMACOLOGY, 2005, 178 (01) : 35 - 40
  • [37] Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial
    Heck, AH
    Haffmans, PMJ
    de Groot, IW
    Hoencamp, E
    SCHIZOPHRENIA RESEARCH, 2000, 46 (2-3) : 97 - 105
  • [38] A Double-Blind, Randomized Comparison Study of Efficacy and Safety of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia and Acute Agitated Behavior
    Chan, Hung-Yu
    Ree, Shao-Chun
    Su, Lien-Wen
    Chen, Jiann-Jyh
    Chou, Sun-Yuan
    Chen, Chih-Ken
    Chen, Ying-Sheue
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (03) : 355 - 358
  • [39] Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study
    Zhang, XY
    Zhou, DF
    Cao, LY
    Zhang, PY
    Wu, GY
    Shen, YC
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (06) : 325 - 330
  • [40] Efficacy and Safety of Levosulpiride Versus Haloperidol Injection in Patients With Acute Psychosis: A Randomized Double-Blind Study
    Lavania, Sagar
    Praharaj, Samir Kumar
    Bains, Hariender Singh
    Sinha, Vishal
    Kumar, Abhinav
    CLINICAL NEUROPHARMACOLOGY, 2016, 39 (04) : 197 - 200